Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CORRECTION OF UK NOTICE CONVENING THE ANNUAL GENERAL MEETING IN DAMPSKIBSSELSKABET NORDEN A/S

ANNOUNCEMENT NO. 51 - 25 FEBRUARY 2021 Unfortunately, the UK notice convening the annual general meeting in Dampskibsselskabet NORDEN A/S mentioned an incorrect weekday for the extraordinary general meeting. For the avoidance of doubt an updated notice is hereby published. The update only relates to the UK version. Kind regards, Dampskibsselskabet NORDEN A/S The Board of Directors For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Report for the period 1 Jan – 31 Dec 2020

October – December 2020 · Net sales amounted to SEK 2.99 m (4.67) · Net operating income was SEK 207,000 (823,000) · The operating profit was SEK 3.47 m (9.29) · The loss for the period was SEK 8.28 m (-7.81) · Earnings per share before and after dilution were SEK -16.55 (-15.62) 1 January– 31 December 2020 · Net sales amounted to SEK 11.25 m (20.20) · Net operating income was SEK -2.67 m (2.33) · The operating loss was SEK 14.58 m (-7.00) · The loss for the period was SEK 61.16 m (-51.18) · Earnings per share before and after dilution were SEK -122.32 (-

84,976 Metsä Board A shares converted into B shares

Metsä Board Corporation Total number of voting rights and capital 25 February 2021 at 1 p.m. EETIn accordance with Section 14 of the Articles of Association of Metsä Board Corporation, 84,976 A shares have been converted into 84,976 B shares. The conversion has been entered into the Trade Register on 25 February 2021 and trading with these shares is estimated to commence on 26 February 2021. The total number of Metsä Board shares is 355,512,746. After the conversion the amount of A shares is 32,802,175 which entitle to approximately 67% of the voting rights in Metsä Board and the amount

Kutsu Nitro Games Oyj:n ylimääräiseen yhtiökokoukseen / Notice to the Extraordinary General Meeting of Nitro Games Oyj

Nitro Games Oyj:n osakkeenomistajat kutsutaan yhtiön ylimääräiseen yhtiökokoukseen, joka pidetään 18.3.2021 klo 14:00 alkaen (Suomen aikaa) Nitro Games Oyj:n Kotkan toimipisteessä osoitteessa Juha Vainion katu 2, 48100 Kotka. Kokoukseen ilmoittautuneiden vastaanottaminen ja äänestyslippujen jakaminen aloitetaan klo 13:30. Osakkeenomistajia kannustetaan käyttämään äänioikeuttaan valtakirjalla henkilökohtaisen osallistumisen sijaan yhtiökokouksen turvallisen järjestämisen mahdollistamiseksi. Nitro Games Oyj tulee arvioimaan ilmoittautuneiden osakkeenomistajien lukumäärää ja yhtiökokouksen

Nectarine Health obtains the last remaining FCC clearance

Brighter's subsidiary Nectarine Health has obtained the last remaining regulatory clearance in the US linked to electronic communications (FCC). Earlier in February, Brighter announced  that clearance had been obtained for two of the three units included in the system. Nectarine Health is continuing its preparations for a US commercial launch, which is planned for the second half of 2021. Nectarine Health recently also announced that the company initiated a test phase ahead of the launch. Read

TePe joins the UNOPS Global Innovation Centre Sweden in a collaborative partnership

TePe joins the UNOPS Global Innovation Centre Sweden (UNOPS GIC) in a collaborative partnership and becomes a member of the UNOPS GIC Sweden community.Taking action to combat climate change and its impacts is one of the greatest challenges of our time. To tackle the challenge and reach the UN Sustainable development goals we need to work together. “At TePe we want to engage in partnerships where we see an opportunity to make a real impact. We are very excited to be part of the UNOPS GIC Sweden Community. It is our strong belief that by sharing knowledge working together we can contribute

The Finnish Competition and Consumer Authority confirms that the conditions on the divestment size in Caverion’s Maintpartner transaction have been fulfilled

Caverion Corporation Stock exchange release 25 February 2021 at 12.15 p.m. EETThe Finnish Competition and Consumer Authority confirms that the conditions on the divestment size in Caverion’s Maintpartner transaction have been fulfilled The Finnish Competition and Consumer Authority (the “FCCA”) has today confirmed that Caverion’s divestment on 30 September 2020 did fulfil the conditions on the divestment size in Caverion’s Maintpartner transaction. According to a stock exchange release published by Caverion on 22 November 2019, the approval of the Finnish Competition and Consumer

The European Patent Office intends to grant Idogen’s patent application relevant to its cell therapy for hemophilia A

Idogen AB has received confirmation that the European Patent Office (EPO) intends to grant a patent application which supports and covers the company’s tolerogenic cell therapy’s application to the severe bleeding disorder, hemophilia A. This patent application was submitted in 2016 and will provide additional protection to the broader patent application for Idogen´s technology which in December 2020 was extended via an International (PCT) application.-This is very positive news from the European Patent Office (EPO). The patent covers Idogen´s technology to inhibit the production of

Notice Convening the Annual General Meeting in Dampskibsselskabet NORDEN A/S

ANNOUNCEMENT NO. 50 – 25 FEBRUARY 2021   25 February 2021 Notice is hereby given that the annual general meeting will convene in Dampskibsselskabet NORDEN A/Sat 3.00 p.m. CET on Thursday 25 March 2021 The General Meeting will be held as a completely electronic general meeting without the possibility of physical attendance. The Annual General Meeting will be held as a completely electronic general meeting and participation in the Annual General Meeting will solely take place via the internet. The electronic general meeting can be accessed by shareholders who have

Alma Media’s Financial Review for 2020 published

Alma Media Corporation                     Stock Exchange Release 25 February 2021 at 12 a.m. (EET)              ALMA MEDIA’S FINANCIAL REVIEW FOR 2020 PUBLISHED Alma Media has published its Financial Review for the financial year 2020. The Financial Review consists of the Board of Directors’ report, the Financial Statements, Corporate Governance Statement and Remuneration Report. All the above statements are attached to this release as a PDF file and are also available on Alma Media’s website https://www.almamedia.fi/en/investors/reports-and-presentations/financial-reports-and-

Kiilto is boldly developing new green packaging adhesive solutions

Kiilto's Promise to the Environment strongly guides the company's product development on a broad front. Kiilto is soon launching new green industrial adhesive solutions for paper and packaging.Kiilto takes account of environmental factors in all its business activities and choices as a family business. Kiilto has, for example, made a strict environmental promise concerning the raw materials it uses: the share of recycled and renewable raw materials will be doubled at chemical plants by 2025. Kiilto also has the ambitious goal of becoming carbon neutral by 2028. Towards more sustainable

Pihlajalinna Plc’s disposal of own shares based on the share-based incentive programme

Pihlajalinna Plc                            Stock Exchange Release          25 February 2021 at 11.45 a.m. Pihlajalinna Plc’s disposal of own shares based on the share-based incentive programme A total of 26,546 treasury shares of Pihlajalinna Plc has been conveyed on 25 February 2021 without consideration to the key persons of the company based on the performance-based earning period 2020 of the share-based incentive programme according to the terms and conditions of the plan. The decision of the Board of Directors is based on a share issue authorization granted by the Annual

Hectic time for FVB in the UK

FVB in the UK has had a hectic time with the implementation of two major district heating projects. FVB has recently provided design services for the development of a large district heating network that will use residual heat supplied by the SELCHP Energy from Waste plant. The heat network is designed to supply a heating output of up to 30 MW for the supply of heat to both residential and commercial properties in the London Brough of Bermondsey district in southeast London. The project is receiving approximately £5 million of HNIP (Heat Network Investment Project) funding and is a key

Resolutions of Loudspring Plc's Extraordinary General Meeting

Loudspring Plc                                           Company Release 25 February 2021 at 11.30 (EET) Resolutions of Loudspring Plc's Extraordinary General Meeting The Extraordinary General Meeting of Loudspring Plc was held on 25 February 2021 in Helsinki. A total of 6 shareholders, 5,033,591 class A shares, 3,213,181 class K shares and 69,297,211 votes were represented in the meeting. The Extraordinary General Meeting resolved on the following issues: Authorizing the Board of Directors to decide on issuance of shares, options and other special rights entitling to

DNB Markets - Episurf Medical: Moving forward despite Covid-19

The company’s overall Q4 report (19 February) was strong, given the headwind among almost all elective procedures in Q4. However, underlying sales still increased YOY in 2020, a good sign. During the year, the amount of published clinical data increased (and should continue to rise in 2021) and this strengthens the company’s competitive position. Focus going forward will be on the EPIC-knee trial and the patellofemoral implant aimed to be filed in the US this year. We have lifted our fair value for the shares to SEK2.5–8 (previously SEK1.9–6.5).Q4 earnings hurt by the pandemic. Sales of

Nordic Nanovector ASA - Share capital increase registered

Oslo, Norway, 25 February 2021 Reference is made to the stock exchange announcement on 23 February 2021 regarding the successful completion of Nordic Nanovector ASA's (OSE: NANOV) (the "Company") private placement of new shares (the "Private Placement"). The share capital increase pertaining to the 15,878,122 new shares, each with a nominal value of NOK 0.20, to be issued in the Private Placement (the "New Shares") has been registered in the Norwegian Register of Business Enterprises (the "NRBE") on 25 February 2021, and the Company's share capital has been increased with NOK 3,175,

Holding(s) in Company

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(to besent to the relevantissuer and tothe FCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the EnQuest PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

NoHo Partners launches new co-operation negotiations to adapt its operations to restaurant closures

NoHo Partners PlcSTOCK EXCHANGE RELEASE 25 February 2021 at 10:45NoHo Partners launches new co-operation negotiations to adapt its operations to restaurant closuresNoHo Partners Plc will start new negotiations in accordance with the Co-operation Act in order to adjust its operations to the closure measures concerning the restaurant industry published by the Finnish Government today, which will enter into force on March 8, 2021. The aim of the negotiations is to minimize the economic impact of the COVID-19 pandemic.The co-operation negotiations cover the entire Group's personnel, i.e.

Ortoma launches new website highlighting market leading AI-assisted surgical solutions

Ortoma is now entering the commercialization phase of Ortoma Treatment Solution™ (OTS™) its AI assisted surgical technology platform for planning and positioning of orthopaedic implants. To emphasize some of the key features, the company has launched a new website: www.ortoma.comOTS™ is an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up. This platform is used at the point of care and provides immediate integration into the hospital system. The

Nordea Bank Abp: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Nordea Bank AbpStock exchange release – Major shareholder announcements25 February 2021 at 10.30 EET Nordea Bank Abp has on 24 February 2021 received a notification under Chapter 9, Section 5 of the Securities Markets Act, according to which BlackRock, Inc.'s indirect shareholding of Nordea Bank Abp’s shares and voting rights crossed the threshold of 5 per cent on 23 February 2021. According to the notification, the total number of Nordea Bank Abp’s shares and voting rights held directly or through financial instruments by BlackRock, Inc. and its funds was 5.06 per cent on 23

Ahlstrom-Munksjö’s Annual & Sustainability Report 2020 has been published

AHLSTROM-MUNKSJÖ OYJ, ANNUAL FINANCIAL REPORT, February 25, 2020 at 10:30 a.m. EET Ahlstrom-Munksjö has today published its Annual & Sustainability Report 2020 on the company’s website http://www.ahlstrom-munksjo.com. “In 2020, we were successful in improving our result and developing our business despite the unprecedented challenges caused by the coronavirus pandemic. Our quick response to the pandemic demonstrated our agility, worldwide teamwork and business mindset combined with a sense of responsibility. The offer is evidence of the good and hard work we have done, and our success

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 49 - 25 FEBRUARY 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Approval of Mellozzan (melatonin)

The pharmaceutical Mellozzan tablets 0.5mg, 1mg, 2mg, 3mg, 4mg and 5mg, has been approved for sale in Sweden by the Medical Products Agency.Mellozzan is a prescription drug used to treat insomnia in children 6 - 17 years of age with ADHD where other sleep support measures are not sufficient. It can also be taken by adults to treat the effects of jet lag for a short time. Mellozzan contains the hormone melatonin, a synthetic form of the body's own hormone that the brain produces to promote sleep. Medicines containing melatonin are available in Sweden in the form of prolonged-release

There are no items matching the current filter
There are no more items matching the current filter
Back to top